Security Snapshot

Parabilis Medicines, Inc. - Common Stock, $0.0001 par value (PBLS) Institutional Ownership

CUSIP: 698955101

13F Institutional Holders and Ownership History from Q2 2026 to Q3 2026

13F reference period

Q3 2026

Institutions Reporting

90

Shares (Excl. Options)

93.3MFull value: 93,295,367 · shares · 30 Sep 2026

Price

$32.29

The headline uses the Q3 2026 reference period after its reporting deadline. Available reports may still be incomplete or amended.

Save this security page for your next review

Watchlists follow companies and investors, across their share classes. Bookmark this page to revisit this specific CUSIP and its quarterly holders. If you create an account from here, we will bring you back after verification.

Latest holder snapshot 5 signals
Portfolio coverage rank
0.01%
Share change
+8,737,453
Value change
+$282,899,112
Number of holders
90
Issuer context Names, identifiers, and filing context for this profile. 2 identity fields
Shares outstanding
120,995,849
SEC-reported price per share
$28.70
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Filing notes and source

Key facts

  • PBLS - Parabilis Medicines, Inc. - Common Stock, $0.0001 par value is tracked under CUSIP 698955101.
  • 90 institutions reported positions in Q3 2026.
  • 3 significant owners is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 79 to 90 between Q2 2026 and Q3 2026.
  • SEC-reported value moved from
    $2.71BFull value: $2,710,461,855 · USD · 30 Jun 2026
    to
    $3.01BFull value: $3,011,631,745 · USD · 30 Sep 2026
    .

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 90 institutions filings for Q3 2026.

Open SEC evidence

Security key

698955101

13F reference period

Q3 2026

13F holders

90

13D/G owners

3

CIK / CUSIP context first

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
3
Security
PBLS
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
RA CAPITAL MANAGEMENT, L.P. 24% 28,933,371 RA Capital Management, L.P. 11 Jun 2026
FMR LLC 8.5% $304,973,738 10,292,735 FMR LLC 30 Jun 2026
ARCH Venture Fund XII, L.P. 5.3% $190,010,671 6,412,780 ARCH Venture Fund XII, L.P. 30 Jun 2026
As of 30 Sep 2026, 90 institutional investors reported holding
93.3MFull value: 93,295,367 · shares · 30 Sep 2026
shares of Parabilis Medicines, Inc. - Common Stock, $0.0001 par value (PBLS). This represents 77% of the company’s total
121MFull value: 120,995,849 · shares · Stored outstanding share count
outstanding shares.

13F concentration

Top 25 institutional shareholders

Largest 13F positions for this security by reported shares and value.

Top holder share
71%
Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
RA CAPITAL MANAGEMENT, L.P. 24% 29,177,964 9.5% $942,156,458
ARCH Venture Management, LLC 5.3% 6,412,780 13% $207,068,666
venBio Partners LLC 4.4% 5,266,697 34% $170,061,646
Alphabet Inc. 4.1% 4,919,498 0.18% $158,850,590
Nextech Invest Ltd. 3.9% 4,663,176 6.7% $150,573,953
Cormorant Asset Management, LP 3.8% 4,615,612 10% $149,038,111
REGENERON PHARMACEUTICALS, INC. 3.4% 4,166,666 75% $134,541,645
Janus Henderson Group Ltd. 2.7% 3,275,946 0.04% $105,772,132
Siren, L.L.C. 2.5% 2,992,259 2.3% $96,620,043
FARALLON CAPITAL MANAGEMENT, L.L.C. 2% 2,368,200 0.4% $76,469,178
Frazier Life Sciences Management, L.P. 1.9% 2,330,750 1.9% $75,259,918
DEERFIELD MANAGEMENT COMPANY, L.P. 1.6% 1,880,704 0.94% $60,727,932
Soleus Capital Management, L.P. 1.4% 1,684,512 1.9% $54,392,892
VANGUARD PORTFOLIO MANAGEMENT LLC 1.3% 1,582,509 0% $51,099,216
VANGUARD CAPITAL MANAGEMENT LLC 1.3% 1,556,246 0% $50,251,183
GENERAL ATLANTIC, L.P. 1.3% 1,538,461 2% $49,676,906
GEODE CAPITAL MANAGEMENT, LLC 0.83% 1,004,945 0% $32,457,598
Foresite Capital Management VI LLC 0.83% 999,044 5.7% $32,259,131
Catalio Capital Management, LP 0.68% 824,043 4.9% $26,608,348
ALLIANCEBERNSTEIN L.P. 0.63% 765,186 0.01% $24,707,856
STATE STREET CORP 0.63% 757,790 0% $24,469,039
Logos Global Management LP 0.62% 750,000 1.4% $24,217,500
Blue Pool Management Ltd. 0.54% 650,568 63% $21,006,841
Casdin Capital, LLC 0.53% 645,690 0.91% $20,849,330
Venrock Adviser, LLC 0.52% 625,000 0.98% $20,181,250

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
2
Headline period
Q3 2026
Rows shown
1-2 of 2
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q3 93,295,367 $3,011,631,745 +$282,899,112 $32.29 90
2026 Q2 98,966,433 $2,710,461,855 +$2,647,752,089 $27.37 79
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .